Advertisement

Introduction

  • Toby K. Eisenstein

Abstract

This symposium is the thirteenth biennial clinical microbiology program sponsored by the Eastern Pennsylvania Branch of the American Society for Microbiology in cooperation with the Philadelphia area medical schools and the Bureau of Laboratories of the Pennsylvania Department of Health. This year a generous contribution from Merck, Sharp and Dohme has helped to make the program a reality.

Keywords

Haemophilus Influenzae Tetanus Toxoid Mouth Disease Generous Contribution Pennsylvania Department 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henderson, D. A. (1976). The eradication of smallpox. Sci. Amer. 235:25.PubMedCrossRefGoogle Scholar
  2. 2.
    Austrian, R. (1981). Pneumococcus: The first one hundred years. Rev. Infect. Dis. Suppl. 3:183.CrossRefGoogle Scholar
  3. 3.
    Carey, R. B., Eisenstein, T. K., Shockman, G. D., Greber, T. F., and Swenson, R. M. (1980). Soluble group-and type-specific antigens from type III group B Streptococcus. Infect. Immun. 28:195–203.PubMedGoogle Scholar
  4. 4.
    Robbins, J. B., Schneerson, R., and Parke, J. C., Jr. (1982). A review of the efficacy trials with Haemophilus influenzae type b polysaccharide vaccines, in Haemphilus influenzae, S. H. Sell and P. F. Wright, eds., Elsevier, New York, pp. 255–264.Google Scholar
  5. 5.
    Jennings, H. J. and Lugowski, C. (1982). Tetanus toxoid conjugates of the meningococcal polysaccharides, in Seminars in Infectious Disease, Vol. IV: Bacterial Vaccines, J. B. Robbins, J. C. Hill and J. C. Sadoff, eds., Thieme-Stratton, New York, pp. 247–253.Google Scholar
  6. 6.
    Sadoff, J. C., Futrovsky, S. L., Sidberry, H. F., Iglewski, B. H., and Seid, R. C., Jr. (1982). Detoxified lipopolysaccharide-protein conjugates, in Seminars in Infectious Disease, Vol. IV: Bacterial Vaccines, J. B. Robbins, J. C. Hill and J. C. Sadoff, eds., Thieme-Stratton, New York, pp. 346–354.Google Scholar
  7. 7.
    Honda, T. and Finkelstein, R. A. (1979). Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc. Natl. Acad. Sci. USA 76:2052.PubMedCrossRefGoogle Scholar
  8. 8.
    Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., and Lerner, R. A. (1982). Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Toby K. Eisenstein
    • 1
  1. 1.Temple University School of MedicinePhiladelphiaUSA

Personalised recommendations